Matthew B. Murphy serves as Executive at Nautilus Biotechnology, Inc., where they oversee executive responsibilities. Since joining the company, Matthew B. Murphy has executed 5 insider transactions totaling $79.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 4, 2025 involved purchasing 20,000 shares valued at $12.8K.
Matthew B. Murphy currently holds 74,140 shares of Nautilus Biotechnology, Inc. (NAUT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew B. Murphy has been a net buyer of NAUT stock. They have purchased $79.0K and sold $0 worth of shares.
Matthew B. Murphy's most recent insider trade was on Sep 4, 2025, when they purchased 20,000 shares at $0.64 per share.
Get notified when new Form 4 filings are submitted
| $2.84 |
| Discretionary |
| Aug 12, 2022 | NAUT | $7.1K | Purchase | 2,500 | $2.85 | Discretionary |
| May 12, 2022 | NAUT | $32.8K | Award | 10,000 | $3.28 | Discretionary |
| Aug 13, 2021 | NAUT | $37.8K | Purchase | 5,000 | $7.56 | Discretionary |